This Viewpoint explains the role of pharmaceutical benefit managers (PBMs) in the United States drug and health care market, and the potential effects acquisitions of PBMs by health insurers could have on prices and drug availability.
No takes yet. Share an insight, caveat, or question.
Schulman et al. (2018) studied this question.